Literature DB >> 23164384

Is a sexual dysfunction domain important for quality of life in men with urological chronic pelvic pain syndrome? Signs "UPOINT" to yes.

Seth N P Davis1, Yitzchak M Binik, Rhonda Amsel, Serge Carrier.   

Abstract

PURPOSE: Clinical phenotyping to guide treatment for urological chronic pelvic pain syndrome is a promising strategy. The UPOINT (urinary, psychosocial, organ specific, infection, neurological/systemic and tenderness of the pelvic floor) phenotyping system evaluates men and women on 6 domains. However, this study focused on men only. Due to the high prevalence of sexual dysfunction in men with urological chronic pelvic pain syndrome, debate exists about the usefulness of adding an (S) (sexual dysfunction) domain to UPOINT. We examined the usefulness in terms of quality of life and delineated urological chronic pelvic pain syndrome subcategories using UPOINT(S) domains.
MATERIALS AND METHODS: We assessed 162 men using UPOINT criteria and after adding the sexual dysfunction domain. Using multiple regression analysis UPOINT(S) criteria were then compared to quality of life, as measured by the SF-36® health outcome survey and Chronic Prostatitis Symptoms Index. Sample subgroups were assessed using k-means cluster analysis.
RESULTS: The total number of UPOINT(S) domains correlated with SF-36 and Chronic Prostatitis Symptoms Index scores. Using regression analysis the 2 significant predictors of SF-36 scores were the psychosocial and sexual domains. Men with sexual dysfunction had significantly worse quality of life than men without the condition. In addition, 6 potentially clinically meaningful subgroups were identified using cluster analysis. Sexual dysfunction was differentially present in these groups.
CONCLUSIONS: Adding a sexual dysfunction domain to UPOINT may help improve quality of life in men treated for urological chronic pelvic pain syndrome.
Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23164384     DOI: 10.1016/j.juro.2012.08.083

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

Review 1.  Classification and treatment of men with chronic prostatitis/chronic pelvic pain syndrome using the UPOINT system.

Authors:  Daniel A Shoskes; J Curtis Nickel
Journal:  World J Urol       Date:  2013-04-16       Impact factor: 4.226

Review 2.  Management of Chronic Prostatitis (CP).

Authors:  Nadir Zaidi; Dominique Thomas; Bilal Chughtai
Journal:  Curr Urol Rep       Date:  2018-08-31       Impact factor: 3.092

3.  Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients.

Authors:  Vittorio Magri; Emanuela Marras; Antonella Restelli; Florian M E Wagenlehner; Gianpaolo Perletti
Journal:  Exp Ther Med       Date:  2014-12-19       Impact factor: 2.447

4.  Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline.

Authors:  Jon Rees; Mark Abrahams; Andrew Doble; Alison Cooper
Journal:  BJU Int       Date:  2015-06-16       Impact factor: 5.588

5.  Evaluation of influence of the UPOINT-guided multimodal therapy in men with chronic prostatitis/chronic pelvic pain syndrome on dynamic values NIH-CPSI: a prospective, controlled, comparative study.

Authors:  Denis V Krakhotkin; Volodymyr A Chernylovskyi; Evgeny E Bakurov; Johann Sperl
Journal:  Ther Adv Urol       Date:  2019-06-26

6.  Corpus cavernosum smooth muscle cell dysfunction and phenotype transformation are related to erectile dysfunction in prostatitis rats with chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Guang-Chun Wang; Tian-Run Huang; Yang-Yang Hu; Ke-Yi Wang; Heng Shi; Lei Yin; Bo Peng
Journal:  J Inflamm (Lond)       Date:  2020-01-06       Impact factor: 4.981

7.  Influence of infection on the distribution patterns of NIH-Chronic Prostatitis Symptom Index scores in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).

Authors:  V Magri; F M E Wagenlehner; E Marras; J W O VAN Till; J Houbiers; P Panagopoulos; G L Petrikkos; G Perletti
Journal:  Exp Ther Med       Date:  2013-06-21       Impact factor: 2.447

8.  Prevalence of sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: a meta-analysis.

Authors:  Hong-Jun Li; De-Ying Kang
Journal:  World J Urol       Date:  2015-11-06       Impact factor: 4.226

9.  Erectile Dysfunction in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Outcomes from a Multi-Center Study and Risk Factor Analysis in a Single Center.

Authors:  Yadong Zhang; Tao Zheng; Xiang'an Tu; Xin Chen; Zhu Wang; Shengfu Chen; Qiyun Yang; Zi Wan; Dayu Han; Haipeng Xiao; Xiangzhou Sun; Chunhua Deng
Journal:  PLoS One       Date:  2016-04-27       Impact factor: 3.240

Review 10.  The Effect of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) on Erectile Function: A Systematic Review and Meta-Analysis.

Authors:  Xiang Chen; ZhiRui Zhou; XiaoChun Qiu; Bin Wang; JiCan Dai
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.